Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,674,138
-$1,779,332 QoQ
Shares Held
235,637
-11.2% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#564
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Derivatives in PFE
reported options exposure · as of Sep 30, 2022CallValue
$16,628,800
CallShares
380,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 20261832 Asset Management L.P. holds $1,536,520,507 across 9 Drug Manufacturers - General names. PFE ranks #7 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
2,162,034 | $549,091,774 | |
| 2 | LLY |
ELI LILLY & Co
|
396,979 | $476,148,561 | |
| 3 | AZN |
Astrazeneca PLC
|
1,215,636 | $230,508,898 | |
| 4 | ABBV |
AbbVie Inc.
|
775,386 | $195,118,133 | |
| 5 | MRK |
Merck & Co., Inc.
|
520,333 | $66,862,790 | |
| 6 | NVS |
Novartis AG
|
51,084 | $8,005,884 | |
| 7 | PFE |
Pfizer Inc
This page
|
235,637 | $5,674,138 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
52,979 | $3,052,649 |
All Filings in PFE
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,674,138 | 235,637 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $7,453,470 | 265,437 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $6,582,813 | 264,370 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $4,959,376 | 194,638 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,886,178 | 201,575 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $20,633,880 | 814,281 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $285,716,957 | 10,769,580 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $155,084,279 | 5,358,821 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $69,890,850 | 2,497,886 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $276,584 | 9,967 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $3,101,230 | 107,719 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $155,139,108 | 4,677,091 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $92,830,550 | 2,530,822 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $72,821,716 | 1,784,846 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $94,733,536 | 1,848,820 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $16,628,800 | 380,000 | Call | Sole | 2023-10-17 | |
| 2022-09-30 | $83,079,979 | 1,898,537 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $19,923,400 | 380,000 | Call | Sole | 2023-10-17 | |
| 2022-06-30 | $81,956,006 | 1,563,151 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $19,672,600 | 380,000 | Call | Sole | 2023-10-17 | |
| 2022-03-31 | $276,850,843 | 5,347,708 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $473,825,821 | 8,024,146 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $370,104,490 | 8,605,080 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $394,994,349 | 10,086,679 | Shares | Sole | 2021-08-20 | |
| 2021-03-31 | $366,674,917 | 10,120,754 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $356,633,096 | 9,688,484 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $363,336,284 | 9,900,181 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $375,692,029 | 11,489,041 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $379,640,287 | 11,631,152 | Shares | Sole | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||